160 related articles for article (PubMed ID: 21968105)
81. Regression of experimental medulloblastoma following transfer of HER2-specific T cells.
Ahmed N; Ratnayake M; Savoldo B; Perlaky L; Dotti G; Wels WS; Bhattacharjee MB; Gilbertson RJ; Shine HD; Weiss HL; Rooney CM; Heslop HE; Gottschalk S
Cancer Res; 2007 Jun; 67(12):5957-64. PubMed ID: 17575166
[TBL] [Abstract][Full Text] [Related]
82. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
[TBL] [Abstract][Full Text] [Related]
83. Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.
Iacovelli L; Orlando R; Rossi A; Spinsanti P; Melchiorri D; Nicoletti F
Curr Opin Pharmacol; 2018 Feb; 38():59-64. PubMed ID: 29525720
[TBL] [Abstract][Full Text] [Related]
84. Coinfection of individual leukocytes with human cytomegalovirus and human immunodeficiency virus is a rare event in vivo.
Bertram S; Hufert FT; van Lunzen J; von Laer D
J Med Virol; 1996 Aug; 49(4):283-8. PubMed ID: 8877760
[TBL] [Abstract][Full Text] [Related]
85. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.
Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
[TBL] [Abstract][Full Text] [Related]
86. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.
Fornara O; Bartek J; Rahbar A; Odeberg J; Khan Z; Peredo I; Hamerlik P; Bartek J; Stragliotto G; Landázuri N; Söderberg-Nauclér C
Cell Death Differ; 2016 Feb; 23(2):261-9. PubMed ID: 26138445
[TBL] [Abstract][Full Text] [Related]
87. A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.
Endersby R; Whitehouse J; Hii H; Greenall SA; Johns TG; Gottardo NG
Neoplasia; 2018 May; 20(5):432-442. PubMed ID: 29574250
[TBL] [Abstract][Full Text] [Related]
88. Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment.
Zou P; Conklin HM; Scoggins MA; Li Y; Li X; Jones MM; Palmer SL; Gajjar A; Ogg RJ
Brain Imaging Behav; 2016 Mar; 10(1):258-71. PubMed ID: 25967954
[TBL] [Abstract][Full Text] [Related]
89. Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets.
Schmidt AL; Brunetto AL; Schwartsmann G; Roesler R; Abujamra AL
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):335-48. PubMed ID: 20438440
[TBL] [Abstract][Full Text] [Related]
90. [Influence of congenital asymptomatic cytomegalovirus infection on development of infants].
Shan RB; Wang XL; Fu P
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):658-61. PubMed ID: 19099851
[TBL] [Abstract][Full Text] [Related]
91. Erratum to 'How we treat medulloblastoma in adults': [ESMO Open Volume 6, Issue 4, August 2021, 100173].
Franceschi E; Seidel C; Sahm F; Pajtler KW; Hau P
ESMO Open; 2021 Dec; 6(6):100327. PubMed ID: 34775301
[No Abstract] [Full Text] [Related]
92. Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells.
Gao F; Zhou Z; Lin Y; Shu G; Yin G; Zhang T
Front Immunol; 2022; 13():830396. PubMed ID: 35464486
[TBL] [Abstract][Full Text] [Related]
93. Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.
Coluccia D; Figuereido C; Isik S; Smith C; Rutka JT
Curr Neurol Neurosci Rep; 2016 May; 16(5):43. PubMed ID: 27021772
[TBL] [Abstract][Full Text] [Related]
94. Absence of human cytomegalovirus infection in childhood brain tumors.
Sardi I; Lucchesi M; Becciani S; Facchini L; Guidi M; Buccoliero AM; Moriondo M; Baroni G; Stival A; Farina S; Genitori L; de Martino M
Am J Cancer Res; 2015; 5(8):2476-83. PubMed ID: 26396923
[TBL] [Abstract][Full Text] [Related]
95. Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients.
Shamran HA; Kadhim HS; Hussain AR; Kareem A; Taub DD; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
Biomed Res Int; 2015; 2015():642652. PubMed ID: 25710012
[TBL] [Abstract][Full Text] [Related]
96. Does the existence of HCMV components predict poor prognosis in glioma?
Ding D; Han S; Wang Z; Guo Z; Wu A
J Neurooncol; 2014 Feb; 116(3):515-22. PubMed ID: 24395349
[TBL] [Abstract][Full Text] [Related]
97. Viruses and human brain tumors: cytomegalovirus enters the fray.
Hawkins C; Croul S
J Clin Invest; 2011 Oct; 121(10):3831-3. PubMed ID: 21968105
[TBL] [Abstract][Full Text] [Related]
98. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
Baryawno N; Rahbar A; Wolmer-Solberg N; Taher C; Odeberg J; Darabi A; Khan Z; Sveinbjörnsson B; FuskevÅg OM; Segerström L; Nordenskjöld M; Siesjö P; Kogner P; Johnsen JI; Söderberg-Nauclér C
J Clin Invest; 2011 Oct; 121(10):4043-55. PubMed ID: 21946257
[TBL] [Abstract][Full Text] [Related]
99. Regarding human cytomegalovirus in neuroblastoma.
Forslund O; Holmquist Mengelbier L; Gisselsson D
Cancer Med; 2014 Aug; 3(4):1038-40. PubMed ID: 24740962
[TBL] [Abstract][Full Text] [Related]
100. Oncogenic role of cytomegalovirus in medulloblastoma?
Hortal AM; Vermeulen JF; Van Hecke W; Bovenschen N
Cancer Lett; 2017 Nov; 408():55-59. PubMed ID: 28844716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
